- STAAR Surgical Reports First Quarter 2024 Results
- STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
- STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
- STAAR Surgical to Report First Quarter Results on May 7, 2024
- STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
- STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
- STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
- STAAR Surgical to Participate in Two Upcoming Investor Conferences
- STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
- STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
More ▼
Key statistics
On Thursday, STAAR Surgical Co (SR3:STU) closed at 37.96, 52.88% above the 52 week low of 24.83 set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.96 |
---|---|
High | 37.96 |
Low | 37.96 |
Bid | 39.05 |
Offer | 40.53 |
Previous close | 43.23 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.13m |
Free float | 48.88m |
P/E (TTM) | 138.56 |
Market cap | 2.11bn USD |
EPS (TTM) | 0.3093 USD |
Data delayed at least 15 minutes, as of May 09 2024.
More ▼